Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

453

HTML

3057

Figures (1-2)

235

Tables (1-2)

229

Sum=3974

Mar 27, 2013 (publication date) through Dec 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Mar 27, 2013; 5(3): 114-119
Published online Mar 27, 2013. doi: 10.4254/wjh.v5.i3.114

Table 2 Procedural details and outcomes

Stents used (n)	48
Stent deployment
Y-configuration	18/35 (51.4%)
T-configuration	17/35 (48.6%)
Technical success	35/35 (100%)
Clinical success	27/35 (77.1%)
Decreased bilirubin levels	27/33 (81.8%)
Serum bilirubin decrease	60.5% (23%-92%)
Survival interval (d), mean (range)	168 (0-1763)
6-mo survival rate	47.10%
Primary patency (d), mean (range)	105 ( 0-719)
Secondary patency (d), mean (range)	181 (100-1763)
Peri-procedural death	2/35 (5.7%)
Major complications	2/35 (5.7%)
Minor complications	6/35 (17.1%)
Hospitalization time (d), mean ± SD	10.2 ± 3.9

Citation: Karnabatidis D, Spiliopoulos S, Katsakiori P, Romanos O, Katsanos K, Siablis D. Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction. World J Hepatol 2013; 5(3): 114-119
URL: https://www.wjgnet.com/1948-5182/full/v5/i3/114.htm
DOI: https://dx.doi.org/10.4254/wjh.v5.i3.114